Religare Enterprises Ltd (RELIGARE) Q2FY26 Concall Summary - Sep-2025 Qtr
Performance Overview
- Religare Enterprises Ltd (REL) is undergoing a significant transformation, marked by a change in promoters to the Burman Group, a reconstituted board, and a renewed focus on profitable growth, sustainability, and compliance.
- The company successfully concluded a preferential issue of warrants for INR 1,500 crores, with the promoter group and other investors participating equally, positioning REL to capitalize on growth opportunities across its subsidiaries.
- The core insurance business, Care Health Insurance, demonstrated strong performance with a 19% growth in Gross Written Premium (GWP) on an 'n' basis and a significant 100% increase in Profit After Tax (PAT) to INR 177 crores for H1 on an 'n' basis.
- The SME lending arm, Religare Finvest Limited (RFL), has resolved all legacy issues, with the RBI lifting the Corrective Action Plan (CAP) and banks removing the fraud classification, rendering it a debt-free and well-capitalized entity ready to restart business.
- The company is actively strengthening its leadership team, having recently onboarded a Group General Counsel and a Group CHRO, with plans for further key hires across all business verticals to drive the next phase of growth.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.